Oxidative stress and the antioxidant enzyme system in the developing brain

Korean Journal of Pediatrics

Volumn 56, Issue 3, 2013, Pages 107-111

  Shim, So Yeon ^a   Kim, Han Suk ^b  

^a Mokdong Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Antioxidants; Brain injuries; Premature infant; Reactive oxygen species

Indexed keywords

ALLOPURINOL; ALPHA TOCOTRIENOL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; MELATONIN; NITRIC OXIDE; PEROXIREDOXIN; REACTIVE OXYGEN METABOLITE; RETINOL; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOREDOXIN; TOCOPHEROL;

BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; BRAIN INJURY; ENCEPHALOMALACIA; HUMAN; HYPEROXIA; HYPOXIA; LUNG DYSPLASIA; MYELIN SHEATH; MYELINATION; NECROSIS; OXIDATIVE STRESS; PHOSPHOLIPID METABOLISM; PREMATURITY; PROTEIN EXPRESSION; RETROLENTAL FIBROPLASIA; REVIEW;

EID: 84875194811     PISSN: 17381061     EISSN: 20927258     Source Type: Journal    
DOI: 10.3345/kjp.2013.56.3.107     Document Type: Review

References (45)

1. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001;50:553-562.
2. Auten RL, Davis JM. Oxygen toxicity and reactive oxygen species: the devil is in the details. Pediatr Res 2009;66:121-127.
3. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994;344:721-724.
4. Saugstad OD. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Paediatr 1996;85:1-4.
5. Sarker AH, Watanabe S, Seki S, Akiyama T, Okada S. Oxygen radical-induced single-strand DNA breaks and repair of the damage in a cell-free system. Mutat Res 1995;337:85-95.
6. Perrone S, Negro S, Tataranno ML, Buonocore G. Oxidative stress and antioxidant strategies in newborns. J Matern Fetal Neonatal Med 2010;23 Suppl 3:63-65.
7. Aspberg A, Tottmar O. Development of antioxidant enzymes in rat brain and in reaggregation culture of fetal brain cells. Brain Res Dev Brain Res 1992;66:55-58.
8. Shivakumar BR, Anandatheerthavarada HK, Ravindranath V. Free radical scavenging systems in developing rat brain. Int J Dev Neurosci 1991;9:181-185.
9. Folkerth RD, Haynes RL, Borenstein NS, Belliveau RA, Trachten berg F, Rosenberg PA, et al. Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human telencephalic white matter. J Neuropathol Exp Neurol 2004;63: 990-999.
10. Chae HZ, Chung SJ, Rhee SG. Thioredoxin-dependent peroxide reductase from yeast. J Biol Chem 1994;269:27670-27678.
11. Chae HZ, Kim HJ, Kang SW, Rhee SG. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res Clin Pract 1999;45:101-112.
12. Manevich Y, Sweitzer T, Pak JH, Feinstein SI, Muzykantov V, Fisher AB. 1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage. Proc Natl Acad Sci U S A 2002;99:11599-11604.
13. Pak JH, Manevich Y, Kim HS, Feinstein SI, Fisher AB. An anti- sense oligonucleotide to 1-cys peroxiredoxin causes lipid peroxidation and apoptosis in lung epithelial cells. J Biol Chem 2002; 277:49927-49934.
14. Miller SL, Wallace EM, Walker DW. Antioxidant therapies: a potential role in perinatal medicine. Neuroendocrinology 2012;96:13-23.
15. Buonocore G, Perrone S, Tataranno ML. Oxygen toxicity: chemistry and biology of reactive oxygen species. Semin Fetal Neonatal Med 2010;15:186-190.
16. Buonocore G, Perrone S, Bracci R. Free radicals and brain damage in the newborn. Biol Neonate 2001;79:180-186.
17. Mavelli I, Rigo A, Federico R, Ciriolo MR, Rotilio G. Superoxide dismutase, glutathione peroxidase and catalase in developing rat brain. Biochem J 1982;204:535-540.
18. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol 1998; 10:248-253.
19. Rhee SG, Kang SW, Jeong W, Chang TS, Yang KS, Woo HA. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol 2005;17:183-189.
20. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995;18:775-794.
21. Rodrigo J, Fernandez AP, Serrano J, Peinado MA, Martínez A. The role of free radicals in cerebral hypoxia and ischemia. Free Radic Biol Med 2005;39:26-50.
22. Davis JM, Auten RL. Maturation of the antioxidant system and the effects on preterm birth. Semin Fetal Neonatal Med 2010;15:191-195.
23. Land SC. Oxygen-sensing pathways and the development of mammalian gas exchange. Redox Rep 2003;8:325-340.
24. Hoang VM, Foulk R, Clauser K, Burlingame A, Gibson BW, Fisher SJ. Functional proteomics: examining the effects of hypoxia on the cytotrophoblast protein repertoire. Biochemistry 2001;40: 4077-4086.
25. Ozawa H, Takashima S. Immunocytochemical development of transferrin and ferritin immunoreactivity in the human pons and cerebellum. J Child Neurol 1998;13:59-63.
26. van Meer G. Transport and sorting of membrane lipids. Curr Opin Cell Biol 1993;5:661-673.
27. Adamo AM, Aloise PA, Pasquini JM. A possible relationship between concentration of microperoxisomes and myelination. Int J Dev Neurosci 1986;4:513-517.
28. Kim HS, Kang SW, Rhee SG, Clerch LB. Rat lung peroxiredoxins I and II are differentially regulated during development and by hyperoxia. Am J Physiol Lung Cell Mol Physiol 2001;280:L1212-L1217.
29. Kim HS, Pak JH, Gonzales LW, Feinstein SI, Fisher AB. Regulation of 1-cys peroxiredoxin expression in lung epithelial cells. Am J Respir Cell Mol Biol 2002;27:227-233.
30. Kim HS, Manevich Y, Feinstein SI, Pak JH, Ho YS, Fisher AB. Induction of 1-cys peroxiredoxin expression by oxidative stress in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2003; 285:L363-L369.
31. Shim SY, Kim HS, Kim EK, Choi JH. Expression of peroxiredoxin 1, 2, and 6 in the rat brain during perinatal development and in response to dexamethasone. Free Radic Res 2012;46:231-239.
32. Mizusawa H, Ishii T, Bannai S., Peroxiredoxin I (macrophage 23 kDa stress protein) is highly and widely expressed in the rat nervous system. Neurosci Lett 2000;283:57-60.
33. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 1998;18:6241-6253.
34. Savman K, Nilsson UA, Blennow M, Kjellmer I, Whitelaw A. Non- protein-bound iron is elevated in cerebrospinal fluid from preterm infants with posthemorrhagic ventricular dilatation. Pediatr Res 2001;49:208-212.
35. Blomgren K, Hagberg H. Free radicals, mitochondria, and hypoxia- ischemia in the developing brain. Free Radic Biol Med 2006;40: 388-97.
36. Reiter RJ, Tan DX. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 2003;58:10-19.
37. Reiter RJ, Tan DX, Osuna C, Gitto E. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci 2000;7:444-458.
38. Palmer C, Towfghi J, Roberts RL, Heitjan DF. Allopurinol admini- stered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr Res 1993;33(4 Pt 1):405-411.
39. Russell GA, Cooke RW. Randomised controlled trial of allopurinol prophylaxis in very preterm infants. Arch Dis Child Fetal Neonatal Ed 1995;73:F27-F31.
40. Traber MG, Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Biol Med 2007;43:4-15.
41. Mandl J, Szarka A, Bánhegyi G. Vitamin C: update on physiology and pharmacology. Br J Pharmacol 2009;157:1097-1110.
42. Nakai A, Shibazaki Y, Taniuchi Y, Oya A, Asakura H, Koshino T, et al. Vitamins ameliorate secondary mitochondrial failure in neo natal rat brain. Pediatr Neurol 2002;27:30-35.
43. Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA, et al. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 1999;340:1962-1968.
44. Tin W, Wiswell TE. Drug therapies in bronchopulmonary dysplasia: debunking the myths. Semin Fetal Neonatal Med 2009;14:383-390.
45. Parad RB, Allred EN, Rosenfeld WN, Davis JM. Reduction of retino- pathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase. Neonatology 2012;102:139-144.